175 related articles for article (PubMed ID: 6356882)
21. [Immunologic laboratory diagnosis of pararheumatic diseases].
Hoppe I
Med Klin; 1977 May; 72(20):886-92. PubMed ID: 327237
[No Abstract] [Full Text] [Related]
22. Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous.
Spârchez M; Delean D; Samaşcă G; Miu N; Spârchez Z
Clin Rheumatol; 2014 May; 33(5):643-7. PubMed ID: 24557079
[TBL] [Abstract][Full Text] [Related]
23. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
24. Antinuclear antibodies in diagnosis and management.
Tan EM
Hosp Pract (Off Ed); 1983 Jan; 18(1):79-84. PubMed ID: 6401273
[TBL] [Abstract][Full Text] [Related]
25. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
26. Rheumatologic Tests: A Primer for Family Physicians.
Ali Y
Am Fam Physician; 2018 Aug; 98(3):164-170. PubMed ID: 30215901
[TBL] [Abstract][Full Text] [Related]
27. [The Ha(La) antibody as a serologic marker of systemic lupus erythematosus].
Lakomek HJ; Wagener S; Schwochau M; Krüskemper HL
Z Rheumatol; 1988; 47(2):86-92. PubMed ID: 3260430
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic significance of antinuclear antibodies in neurologic patients.
Michielsens B; Walravens M; Vermylen J; Carton H
Acta Neurol Scand; 1991 Aug; 84(2):102-6. PubMed ID: 1950446
[TBL] [Abstract][Full Text] [Related]
29. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB
Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447
[TBL] [Abstract][Full Text] [Related]
31. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
32. [The clinical heterogeneity of systemic lupus erythematosus].
Mazepa MA
Lik Sprava; 1997; (3):25-30. PubMed ID: 9377347
[No Abstract] [Full Text] [Related]
33. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
34. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
Monegat JN; Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
[No Abstract] [Full Text] [Related]
35. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
37. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
38. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.
Anis S; Fatima A; Abdul Jabbar S; Arain T
Immunol Res; 2023 Apr; 71(2):267-275. PubMed ID: 36456720
[TBL] [Abstract][Full Text] [Related]
39. [Immunological diagnosis of connective tissue diseases (author's transl)].
Helmke K
Immun Infekt; 1981 Nov; 9(6):213-22. PubMed ID: 6978279
[TBL] [Abstract][Full Text] [Related]
40. [Clinico-immunological aspects of antinuclear antibodies in systemic lupus erythematosus].
Speranskiĭ AI; Aroian AA; Ivanova SM; Panasiuk AF; Riazantseva TA
Revmatologiia (Mosk); 1987; (3):28-34. PubMed ID: 2446367
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
